Literature DB >> 18055481

Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon?

Axel Franke1, Wolfgang Lante, Lothar G Zoeller, Edmund Kurig, Christian Weinhold, Andreas Markewitz.   

Abstract

HLA-DR expression on peripheral blood monocytes is reduced after cardiac surgery. Little is known about the reconstitution of HLA-DR expression on peripheral blood monocytes in patients suffering from early non-fatal perioperative complications. We conducted a prospective study to prove whether these complications adversely affect the recovery of HLA-DR expression. Before surgery (d0), on the first (d1), third (d3), fifth (5th) postoperative days, blood samples were collected from 90 patients who underwent elective cardiac surgery with cardiopulmonary bypass (CPB). HLA-DR expression was analysed flow cytometrically. Eleven patients experienced postoperative complications [mechanical ventilation of 24-48 h (n=6); reinstitution of CPB (n=2) intraoperatively; laparotomy (n=1), re-thoracotomy (n=1), re-intubation (n=1) within the first 24 h after surgery]. All patients showed a reduced HLA-DR expression after surgery with nadirs at d1 and d3. Whereas the values increased from d3 to d5 in patients with an uneventful clinical course, HLA-DR expression remained suppressed in patients with complications. HLA-DR expression is reduced after cardiac surgery with CPB. A delayed recovery of HLA-DR expression is seen in patients with early perioperative complications. These non-fatal complications appear to represent a 'second hit' resulting in a prolonged deficiency of the innate immune system. This might predispose to further infectious and septic complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055481     DOI: 10.1510/icvts.2007.158899

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  6 in total

1.  Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation.

Authors:  Oh Yoen Kim; Antoine Monsel; Michèle Bertrand; Pierre Coriat; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2010-04-13       Impact factor: 9.097

Review 2.  Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers.

Authors:  Carmen Andrea Pfortmueller; Christian Meisel; Michaela Fux; Joerg C Schefold
Journal:  Intensive Care Med Exp       Date:  2017-10-23

3.  Monocyte Metabolism and Function in Patients Undergoing Cardiac Surgery.

Authors:  Daniel Mayer; Marc Altvater; Judith Schenz; Rawa Arif; Matthias Karck; Florian Leuschner; Markus A Weigand; Florian Uhle; Christoph Lichtenstern
Journal:  Front Cardiovasc Med       Date:  2022-07-13

4.  Flow cytometry-based high-throughput RNAi screening for miRNAs regulating MHC class II HLA-DR surface expression.

Authors:  Maja Houseman; Melody Ying-Yu Huang; Markus Huber; Matthias Staiger; Lan Zhang; Anneliese Hoffmann; Christoph Lippuner; Frank Stüber
Journal:  Eur J Immunol       Date:  2022-06-09       Impact factor: 6.688

5.  Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry.

Authors:  Paul F Rühle; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

6.  Effects of perioperative transcutaneous electrical acupoint stimulation on monocytic HLA-DR expression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass: study protocol for a double-blind randomized controlled trial.

Authors:  Wen-Ting Chen; Jin-Feng Wei; Lan Wang; Deng-Wen Zhang; Wei Tang; Jian Wang; Yue Yong; Jing Wang; Ya-Lan Zhou; Lan Yuan; Guo-Qiang Fu; Sheng Wang; Jian-Gang Song
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.